1. Home
  2. CCNE vs SVRA Comparison

CCNE vs SVRA Comparison

Compare CCNE & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$34.02

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.37

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
SVRA
Founded
1865
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
CCNE
SVRA
Price
$34.02
$5.37
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$34.50
$7.33
AVG Volume (30 Days)
109.6K
1.3M
Earning Date
04-20-2026
05-13-2026
Dividend Yield
2.51%
N/A
EPS Growth
4.18
N/A
EPS
1.79
N/A
Revenue
N/A
N/A
Revenue This Year
$23.21
N/A
Revenue Next Year
$7.00
$430.87
P/E Ratio
$19.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.90
$3.34
52 Week High
$36.17
$7.01

Technical Indicators

Market Signals
Indicator
CCNE
SVRA
Relative Strength Index (RSI) 44.69 48.32
Support Level $32.89 $5.16
Resistance Level $35.17 $5.48
Average True Range (ATR) 0.68 0.20
MACD -0.03 -0.00
Stochastic Oscillator 34.18 49.52

Price Performance

Historical Comparison
CCNE
SVRA

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: